The Latest Breaking News from the Food and Drug Administration

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

The World Health Organization's cancer research arm deemed aspartame as possibly carcinogenic to humans, but the Food and Drug Administration doesn't agree.

Opill becomes the first hormonal birth control pill in the United States to be approved for over-the-counter sale by the Food and Drug Administration.

The Food and Drug Administration on Thursday approved Opill, making it the nation’s first over-the-counter birth control pill.

The influencer-backed energy drink Prime is popular among children but lawmakers and health experts are concerned over its potentially dangerous levels of caffeine.

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

The Food and Drug Administration rejected a high-dose version of Regeneron's eye drug Eylea on Tuesday, leading REGN stock to crumble.

The Associated Press has found that the Food and Drug Administration can't keep up with a flood of illegal disposable e-cigarettes from China

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.